Biotechs big winners in VC rebound

Biotechs big winners in VC rebound

Biotechnology companies are leading a rebound in venture capital investment in the New York metro area, a new survey shows.

Investors put $380 million into 56 companies in the second quarter of this year, for a 63% jump in venture capital investment over the first quarter, according to the MoneyTree Survey by PricewaterhouseCoopers, Thomson Venture Economics and the National Venture Capital Association.


Leave a Reply

Your email address will not be published. Required fields are marked *

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Subscribe!